XYOSTED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xyosted, and when can generic versions of Xyosted launch?
Xyosted is a drug marketed by Antares Pharma Inc and is included in one NDA. There are twenty-three patents protecting this drug.
The generic ingredient in XYOSTED is testosterone enanthate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xyosted
A generic version of XYOSTED was approved as testosterone enanthate by NEXUS on June 14th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for XYOSTED?
- What are the global sales for XYOSTED?
- What is Average Wholesale Price for XYOSTED?
Summary for XYOSTED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for XYOSTED |
| What excipients (inactive ingredients) are in XYOSTED? | XYOSTED excipients list |
| DailyMed Link: | XYOSTED at DailyMed |
US Patents and Regulatory Information for XYOSTED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
